Christian Weyer, EVP, Research & Development at INTERCEPT PHARMACEUTICALS, INC. (ICPT), sold 470 shares at $87.62 ($40K) on 2020-02-27, disclosed to the SEC on 2020-02-28.
Scheduled sale ($40k) by EVP, Research & Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.39 | 357 | $30K | 75.5% |
| 2 | $87.62 | 113 | $10K | 24.5% |
| Total | $85.93 avg | 470 | $40K | 100% |
| Filing → |
| ICPT | SELL | 2019-12-30 | $390K | — | Filing → |
| ICPT | SELL | 2019-12-02 | $106K | — | Filing → |
| ICPT | SELL | 2019-11-27 | $623K | — | Filing → |